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Background: Neuroimaging is important for determining etiology and guiding care in
early childhood epilepsy. However, access to appropriate imaging in sub-Saharan Africa
is modest, and as a consequence, etiological descriptions of childhood epilepsy in the
region have been limited. We sought to describe MRI findings in children with epilepsy
presenting to a tertiary hospital in Nairobi, Kenya, over a 6-year period of routine care.
Materials and Methods: We undertook a retrospective review of MRI findings of
children aged between 0 and 18 years with a diagnosis of epilepsy presenting to
the pediatric neurology department of Aga Khan University Hospital in Nairobi, Kenya,
between January 2014 and July 2020. Over this period, the hospital had 1.5T MRI
machines (GE1.5T Signa Excite and GE 1.5T Signa Explorer) and a 3T MRI machine
(Philips 3T Ingenia). MRI images were independently reviewed by two study radiologists,
and the findings were summarized and categorized into a study database. Related
clinical and electroencephalographic (EEG) details were extracted from patient records.
Categorical data analysis methods were applied to investigate for relationships between
clinically relevant neuroimaging findings and key clinical and EEG observations.
Results: Over the study period, 288 children with a confirmed diagnosis of epilepsy had
an MRI. They were of median age of 6 [interquartile range (IQR) 2–11] years. Ninety-five
(33%) children had abnormal findings on imaging. The most common findings were
encephalomalacia related to chronic infarcts (n = 18: 6.3%), cerebral atrophy (n = 11:
3.8%), disorders of neuronal migration (n = 11: 3.8%), periventricular leukomalacia (n = 9:
3.1%), and hippocampal sclerosis (n = 8: 2.8%). Findings related to infectious etiology
were only observed in four children. Clinical comorbidity and inter-ictal epileptiform activity
on EEG were independently associated with abnormal findings on imaging.
Conclusion: Up to a third of the children who underwent an MRI had a positive yield for
abnormal findings. Imaging findings related to infectious etiologies were little observed
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in our cohort, in contradistinction to etiology studies in similar settings. At the time of
the study, comorbidity and inter-ictal epileptiform activity on EEG were associated with
abnormal findings on imaging and should be considered in informing prioritization for
imaging in childhood epilepsy in this setting.
Keywords: epilepsy, child, Africa, magnetic resonance imaging, seizure

BACKGROUND

description of imaging findings in children with epilepsy in
SSA. We have not come across studies that detail their MRI
findings in the context of a consistent MRI access protocol.
There is need to have better descriptions of imaging findings
in childhood epilepsy in SSA and to align imaging guidelines
with considerations for the unique etiological profiles and the
resource limitations in this setting. These observations can be
complemented by EEG studies that are more accessible and
could have a role in discerning and prioritizing candidates for
imaging in the context of limited resources (13).
We sought to describe MRI findings of children with epilepsy
seen at our center between 2014 and 2020 and to determine
the association between clinical and EEG findings and clinically
relevant findings on neuroimaging.

Recent studies estimate the prevalence of active convulsive
epilepsy in Sub-Saharan Africa (SSA) at 7.0–14.8 per 1,000
people (1, 2). This is about double the estimate of 4.5–5.0 per
1,000 people in Europe (3). This pronounced burden is likely
attributable to greater occurrence of central nervous system
infections, perinatal insults, and traumatic brain injury (1, 4).
These etiologies are more relevant in childhood, and with the
recognized greater manifestation of genetic causes and structural
abnormalities in early life, they altogether present an even
considerable burden of epilepsy disease for children in SSA.
The burden of childhood epilepsy in SSA exists in the context
of limited capacity for care, diagnostics, and treatment. Most
countries in SSA have just a handful of pediatric neurologists
and <1 physician per 1,000 (5, 6). Magnetic resonance imaging
(MRI), the preferred imaging modality for epilepsy, is poorly
accessible at 0.48 per million of the population even in the
best of settings (7). Access to genetic testing services is very
limited (4, 8). This lean diagnostic capacity is associated with
an epilepsy treatment gap of up to 85% (2). Related to this is
a poor description of etiology of childhood epilepsy in SSA.
Early-onset epilepsy occurs in the critical time period of physical,
psychosocial, and mental growth and development. Determining
etiology and defining specific epilepsy syndromes where possible
are important in guiding treatment and prognosis and optimizing
the various aspects of developmental support in early life.
Imaging is crucial for making such determination.
Neuroimaging is important in establishing etiology, providing
prognosis, and planning appropriate care. The International
League Against Epilepsy (ILAE) recommends neuroimaging
for children younger than 2 years except in febrile seizures,
where there is evidence for localization-related epilepsy with the
exception of typically benign idiopathic epilepsy, in abnormal
neurological examination, and in childhood epilepsy refractory
to the initial two antiepileptic drugs (9). MRI is the preferred
imaging modality of choice because of better anatomic definition
and characterization of pathology (9). Computed tomography
(CT) scan may not identify a number of abnormalities apparent
on MRI but is more widely available, less costly, and mostly does
not require sedation of the child. CT scan is easier to deploy
in emergency situations and can detect tumors, malformations,
stroke, and calcified and bone lesions (10). However, it has a
relatively poor yield in identifying focal brain lesions (10).
Access to neuroimaging (MRI and CT scans) and
neurophysiological testing [electroencephalography (EEG)]
is typically concentrated in large urban centers in SSA (11, 12).
Accordingly, there are few studies that have provided a
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MATERIALS AND METHODS
We undertook a retrospective observational study of children
with a primary diagnosis of epilepsy who underwent care and
neuroimaging care at our center between January 2014 and
July 2020.

Study Setting
We conducted the study at the pediatric neurology department of
the Aga Khan University Hospital (AKUH), in Nairobi, Kenya.
AKUH is a tertiary hospital with a cosmopolitan catchment
population that includes referrals from other parts of the
country. There is no known endemic neurological disease in
the immediate catchment population of Nairobi. The pediatric
neurology department runs four clinics in a week, each with an
approximate attendance of 15–20 patients. Approximately 70%
of children seen at these clinics have epilepsy. Over the study
period, this service was mostly supported by one neurologist
and several pediatricians and pediatric registrars. The hospital
has three MRI machines (GE1.5T Signa Excite, in place from
2012–2016; GE 1.5T Signa Explorer from 2016 to date; and
Philips 3T Ingenia, in place since 2013 to date). The radiology
department is supported by eight consultant radiologists, of
whom two are neuroradiologists. The hospital’s neurophysiology
department has two 21-lead EEG machines and is supported by a
neurophysiology team of three.

Study Population
This study recruited all children aged 0–18 years who had been
diagnosed with epilepsy according to the ILAE 2014 epilepsy
guidelines and had undergone imaging at the hospital’s imaging
department. Children with seizures that were documented only
in association with febrile illnesses were excluded from the study.
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The study did not consider imaging results undertaken at other
centers outside the hospital.

comorbidity details, age, gender, and a brief clinical summary. It
was assumed that data on final diagnosis and comorbidity had
taken into consideration clinical details on seizure semiology,
investigations, physical examination findings, and other relevant
clinical findings. EEG reports for patients who had monitoring
at the hospital were retrieved and their details were abstracted
into the study database, linking to the available imaging and
clinical data.

Standard Care
Children reviewed at the pediatric neurology presented as
referrals from other pediatric clinics, hospitals, or the general
outpatient department. The majority of clinic attendees were
newly diagnosed cases. A diagnosis of epilepsy was made on
history and examination as guided by ILAE guidelines, with the
main working principle being history of unprovoked seizures
occurring at least 24 h apart; extended after 2014 to consider
diagnosis of an epilepsy syndrome and occurrence of only one
seizure episode but with the possibility of suffering another
seizure episode (14). Upon confirmation of a diagnosis of
epilepsy, the children were started on antiepileptic drugs as
guided by standard norms of treatment and in consideration
of the child’s age, existing comorbidity, cost of medication,
and history of adverse effects. Assessment for comorbidities
including attention deficit/hyperactivity disorder (ADHD),
autism spectrum disorder (ASD), and developmental delay was
done using clinical assessment criteria set out in Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM 5),
for ADHD and ASD and the Molteno Adapted Scale (validated
for use in African populations) for developmental delay (14).
Most children underwent routine EEG. MRI was considered for
eligible children as per ILAE guidelines. Imaging was carried out
using 1.5T MRI GE Signa Excite (2012–2016), 3T MRI Philips
Ingenia (preferentially), and 1.5T MRI GE Signa Explorer (2017–
2020). Choice of use of either a 1.5T or 3T machine was based
on availability. The following sequences were applied: coronal
T2 and FLAIR at 2-mm thickness and 1.5-mm spacing; axial
T1, T2, FLAIR, T2 sagittal, all at 4-mm thickness and 2-mm
spacing; diffusion-weighted imaging (DWI) at 4-mm thickness
and 1-mm spacing; and coronal T1-weighted volume sequence
at 1.2-mm thickness, no spacing. If contrast was considered
necessary following review by radiologist and the attending
neurologist, contrast was administered (gadodiamide, Omniscan,
GE Healthcare, at 0.2 ml/kg), and post contrast T1 was acquired
in all planes. All MRI images were reviewed and reported by a
consultant radiologist, and the same was captured and stored
in the hospital Picture Archiving and Communication System
(PACS), available for review for up to 10 years from date of
storage. Patients could choose to undertake imaging at another
facility, in which case the results were documented in the clinical
notes but the image films were retained by the patient.

Data Management and Analysis
Patient data were deidentified during entry into the study
database (Open Data Kit). Data analysis was undertaken using
Intercooled STATA (version 13.0, StataCorp LP). The outcome
of interest was findings on MRI. EEG report findings and
clinical details were appropriately categorized for analysis.
Kappa inter-rater statistics was applied to compare imaging
findings between the two radiologists. Most of the data were
categorical, and these were analyzed using chi-square test
to determine significant associations with abnormal imaging
findings. Multivariable logistic regression was applied to identify
clinical and EEG findings that were independently associated
with positive findings on MRI.

Ethical Considerations
Approval to do the study was sought from the AKUH human
ethics research committee and the National Commission for
Science, Technology and Innovation (NACOSTI). Being a
retrospective study, the data sought had been collected as part of
routine care, no biological sample was collected, and the study
was not investigating experimental or new protocols. As such,
consent from individual study subjects was waived. Individual
patient data were anonymized, and the study database was
password protected and accessible only to the study investigators.
There were defined minimal risks of confidentiality breach
for patients involved in the study, but this was mitigated
by appropriate data security measures and deidentification of
personal data. The study was considered to have potential in
improving the care for children with epilepsy.

RESULTS
Between January 2014 and July 2020, 340 children seen at the
pediatric neurology and developmental pediatrics departments
with a working diagnosis of epilepsy underwent MRI at the
hospital’s imaging department. They were of median age of
6 [interquartile range (IQR) 2–11] years. Upon review of
related clinical records, 52 children with alternative diagnoses
were dropped from further analysis (Figure 1). Significant
comorbidities were documented in 23% of the children (n =
66), the most common being global developmental delay or
regression in 9% (n = 26); chronic headaches in 5% (n =
13); and ADHD, autism, and behavioral abnormalities in 3%
(n = 8). Other comorbid conditions included speech delay,
impaired vision, hemiplegia, hydrocephalus, microcephaly,
diabetes, precocious puberty, and other conditions that were
observed with smaller frequencies.

Study-Specific Procedures
Patients with a primary diagnosis of epilepsy who underwent
MRI were identified from the pediatric neurology clinic
attendance database and the hospital’s PACS. Two study
radiologists (SW and JM) independently reviewed the MRIs
and entered their findings into a study database. These findings
were reviewed for congruence, and if there were significant
discrepancies, the images were re-presented to the radiologists
for joint review and determination of consensus findings. On
account of the format of data storage, the clinical data available
from the clinic attendance database were limited to diagnosis and
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TABLE 1 | Summary of imaging findings.
Imaging findings

Frequency

Normal findings

Median age in months (IQR)

193 (67.0%)

84 (36–144)

Encephalomalacia/chronic infarcts

18 (6.3%)

48 (12–156)

Cerebral atrophy

11 (3.8%)

12 (12–36)

Disorders of neuronal migration

11 (3.8%)

84 (5–120)

Periventricular leukomalacia

9 (3.1%)

24 (12–36)

Hippocampal sclerosis

8 (2.8%)

66 (30–156)

Choroidal and arachnoid cysts

7 (2.4%)

60 (48–72)

Hydrocephalus

4 (1.4%)

–

Others

27 (9.4%)

–

IQR, interquartile range.

Relationship Between Clinical,
Electroencephalographic, and Imaging
Findings
The presence of comorbidity and age ≤ 5 years were significantly
associated with abnormal imaging findings (Table 2). Inter-ictal
epileptiform EEG activity was also associated with abnormal
findings on imaging. The other EEG findings were not
significantly associated with abnormal imaging findings. On
applying multivariable logistic regression, comorbidity and
inter-ictal epileptiform EEG report finding were independently
associated with abnormal imaging finding (Table 3).

FIGURE 1 | Study flowchart.

Imaging Findings
The two radiologists (JM and SW) who reviewed the images
had strong inter-rater agreement (kappa = 0.81). About a
third of the children (n = 95) who underwent imaging had
abnormal findings on imaging. The most common findings were
encephalomalacia related to chronic infarcts, cerebral atrophy,
disorders of neuronal migration, periventricular leukomalacia,
and hippocampal sclerosis (Table 1). The identified disorders of
neuronal migration included focal cortical dysplasia, pachygyria,
lissencephaly, and subcortical heterotopia. Imaging findings
of cerebral atrophy and periventricular leukomalacia were
likely to be observed in younger children (<36 months). There
were no consistent relationships between the various imaging
findings and age. Only four children had findings suggestive of
an infectious etiology: two with features of meningoencephalitis,
one with tuberculoma, and one with a septic embolus with
abscesses. Three patients had hippocampal post-ictal changes.
Findings related to hemiconvulsion-hemiplegia, tuberous
sclerosis, neurofibromatosis, and diffuse glioma were observed
in two children each. Other significant abnormal findings were
observed in singular frequency.

DISCUSSION
MRI is fundamentally important and has become increasingly
relevant in the evaluation and management of childhood
epilepsy: supporting elucidation of etiology, syndrome
description, prognostication, and determination of opportunities
for definitive interventions (9). Identification of focal brain
lesions on MRI has supported the scale-up of surgical
interventions, delivering favorable outcomes for epilepsy
conditions that were hitherto associated with refractory seizures
and poor outcomes (9, 10, 15). In infectious pathologies, it is
useful in discerning etiological agents and supporting targeted
and adequate microbial care. MRI is essentially an indispensable
tool in an optimally functioning center that cares for people
with epilepsy. However, MRI practices are variable worldwide,
particularly in SSA, on account of disparate resources, technical
capacity, and infrastructure (7, 9). Identifying candidates for
priority access is useful in informing judicious use where
resources are limited.
Our study reveals a 33% yield in abnormal MRI findings
out of the children with epilepsy who underwent imaging
in our study. The most common imaging findings were
encephalomalacia related to chronic infarcts, cerebral atrophy,
disorders of neuronal migration, periventricular leukomalacia,
and hippocampal sclerosis. A retrospective observational study
of childhood epilepsy presentation at a tertiary hospital in
South Africa with access to CT and MRI revealed abnormalities
in 34% of the children, most common being features of

Electroencephalographic Findings
Forty-nine percent (n = 140) of the imaged children underwent
routine EEG at the hospital’s neurophysiology department.
Thirty-two percent (n = 46) were documented to have
generalized (22%) and focal (78%) interictal epileptiform
discharges. Focal or diffuse slowing was reported in 17 (6%)
children; 53% of them independent of inter-ictal epileptiform
activity. Only seven children (5%) were reported to have
asymmetrical background.
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TABLE 2 | The relationship between electroencephalographic (EEG) and clinical features and abnormal imaging findings.
Clinical and EEG findings

Abnormal imaging findings n/N (%)

Normal imaging n/N (%)

Age ≤ 5 years

52/133 (39%)

81/133 (61%)

Age > 5 years

43/155 (28%)

112/155 (72%)

Presence of comorbidity

35/66 (53%)

31/66 (47%)

No documented comorbidity

60/222 (27%)

162/222 (73%)

Inter-ictal epileptiform EEG activity

19/45 (42%)

26/45 (58%)

No inter-ictal epileptiform EEG activity

18/95 (19%)

77/95 (81%)

EEG slowing

7/17 (41%)

10/17 (59%)

No documented EEG slowing

30/123 (30%)

93/123 (70%)

Asymmetrical EEG background

3/7 (43%)

4 (57%)

Symmetrical EEG background

34/133 (26%)

99/133(74%)

Univariable
OR (95% CI)

P-Value

1.67 (1.01, 2.76)

0.04

3.04 (1.70, 5.47)

<0.01

3.13 (1.39, 7.03)

<0.01

2.17 (0.75, 6.28)

0.14

0.46 (0.10, 2.17)

0.31

OR, odds ratio.

to infectious etiology were not as commonly seen in our study
as has been reported in other studies, an observation that
demonstrates the heterogeneity of the SSA setting. Imaging
is not complete in determination of infectious etiology, and
it is possible that the observed imaging findings related to
infectious etiology represent an underestimate of infectious
etiology in the children in our study. However, these findings
could also be on account of the declining impact of infectious
etiologies on epilepsy morbidity in our setting, attributable to
the success of public health interventions that include widescale water and sanitation programs, HIV/AIDs prevention
and care programs, and universal Haemophilus infleunzae and
Streptococcus pneumoniae vaccination programmes (18). Other
studies suggesting greater occurrence of infectious etiology may
have been biased to settings in which some of the infectious
etiologies are endemic.
Comorbidity was independently associated with greater
odds of positive imaging findings. We observed significant
comorbidity in 23% of our children, a much lower finding than
a previous observation of 54% neurobehavioral comorbidities
in children with lifetime epilepsy in rural Coastal Kenya (19).
Admittedly, ours is a retrospective study, and an assumption
is being made that all the children were uniformly assessed for
comorbidity, notwithstanding that such determination was not
the primary aim of our study. Occurrence of comorbidity in
epilepsy is an evolving clinical scenario, and our observations
at a particular time period and age are not representative of
lifetime prevalence. Further, it would be expected that children
seen at a tertiary facility would have complicated epilepsies
with associated greater comorbidity. However, like in most
SSA settings, because of a suboptimal health system and a
broken referral scheme, our hospital functions as a primary,
secondary, and tertiary facility in one, and the profile of
her catchment is not necessarily constituted only of patients
requiring tertiary health services. It would certainly be useful to
undertake a prospective study using consistent clinical criteria
to determine the prevalence of comorbidity and etiology of
childhood epilepsy in urban and rural facilities that likely have
different disease profiles.

TABLE 3 | Multivariable logistic regression analysis of electroencephalographic
(EEG) and clinical findings’ association with abnormal imaging findings.
Variables

OR
(multivariable)

95% CI

P-Value

Comorbidity

3.603278

1.44, 9.01

Age ≤ 5 years

1.308164

0.56, 3.06

0.54

Interictal_EEG

3.082167

1.36, 6.99

<0.01

<0.01

OR, odds ratio.

perinatal hypoxic insult, disorders of neuronal migration, and
neurocutaneous disorders (11). In this study, CT and MRI
scans were prioritized for children with a history of trauma,
with no obvious underlying cause, as part of a metabolic
assessment, and in those with refractory epilepsy. A smaller
case-control study in Tanzania revealed abnormalities in 29%
of the children who had CT scans, describing brain atrophy
and features of perinatal insults as the most common positive
findings (16). Both studies show similar proportions of positive
imaging yield. They also reveal an etiological profile that
identifies perinatal insults as one of the most common findings:
recognizing a preventable cause of epilepsy that calls for
deliberate ameliorating interventions in maternal and newborn
health. A Bhutan study that included adults and excluded
children under the age of 5 years reported abnormal MRI
findings in 81% of the patients, the most common findings
being mesial temporal sclerosis and neurocyticercosis (17).
Accordingly, different settings will have different observations
in yield and profile description on imaging, underscoring the
importance of a well-conducted childhood imaging description
for our setting. Admittedly, some of our imaging findings
are nonspecific in respect to etiological relationships, and
observations of arachnoid and choroidal cysts were likely
incidental. Significant observations of focal lesions in our
study indicate the opportunity for surgical interventions in
care in our setting, calling for the need for deliberate
development of capacity for epilepsy surgery. Findings related
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Inter-ictal epileptiform EEG activity was also independently
associated with abnormal imaging findings. In our setting, EEG
services to complement epilepsy care are becoming increasingly
widely available, albeit with challenges in upholding quality in
conduct and reporting. Considering their relatively lower costs,
EEG services are scalable. It is feasible to consider applying EEG
study findings and clinical findings of comorbidity to determine
priority in access to MRI services where resources are limited.
Ours was a retrospective study, and it has attendant
weaknesses associated with this design. These include missing
data from EEG and clinical observations. We omitted imaging
and EEG data from studies not done at our center because of
our inability to confirm the validity of the reported findings,
potentially introducing selection bias in our observations. With
a prospective design, we would have had access and opportunity
to review MRI images from other centers, allowing for a
more complete description. We also acknowledge the risk of
misclassification bias in our assessment of imaging, clinical, and
EEG findings. To mitigate this, we reviewed imaging and EEG
records for accuracy.
Our study included a sizable number of children with epilepsy
who underwent MRI in the context of a consistent imaging
protocol. It provides a description of imaging findings of children
with epilepsy from a cosmopolitan background in this setting,
representing greater generalizability in findings than has been
provided by other studies in the same setting. Overall, we
provide a description of imaging findings in childhood epilepsy
in SSA, providing greater insights on etiology of childhood
epilepsy in our setting and defining the opportunity for surgical
interventions and promoting public health interventions that
facilitate access to optimal skilled delivery services.
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